Abramowitz Matthew K
Division of Nephrology, Department of Medicine, and
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York
J Am Soc Nephrol. 2017 Mar;28(3):726-734. doi: 10.1681/ASN.2016070780. Epub 2016 Nov 23.
The optimal approach to managing acid-base balance is less well defined for patients receiving hemodialysis than for those receiving peritoneal dialysis. Interventional studies in hemodialysis have been limited and inconsistent in their findings, whereas more compelling data are available from interventional studies in peritoneal dialysis. Both high and low serum bicarbonate levels associate with an increased risk of mortality in patients receiving hemodialysis, but high values are a marker for poor nutrition and comorbidity and are often highly variable from month to month. Measurement of pH would likely provide useful additional data. Concern has arisen regarding high-bicarbonate dialysate and dialysis-induced alkalemia, but whether these truly cause harm remains to be determined. The available evidence is insufficient for determining the optimal target for therapy at this time.
与接受腹膜透析的患者相比,对于接受血液透析的患者,管理酸碱平衡的最佳方法尚不太明确。血液透析的干预性研究有限,且研究结果不一致,而腹膜透析的干预性研究有更令人信服的数据。接受血液透析的患者血清碳酸氢盐水平过高或过低均与死亡风险增加相关,但高值是营养不良和合并症的标志,且往往每月变化很大。测量pH值可能会提供有用的额外数据。人们对高碳酸氢盐透析液和透析引起的碱血症产生了担忧,但这些是否真的会造成损害仍有待确定。目前现有证据不足以确定最佳治疗目标。